Examples of using Objective response rate in English and their translations into Swedish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Official/political
-
Computer
-
Programming
-
Political
Objective response rate CR+ PR.
P-value< 0.0001 Objective Response Rate.
Objective Response Rate% 95% CI.
At six weeks, the objective response rate(ORR) was 43%;
Objective Response Rate Based on IRR.
Secondary efficacy endpoints were objective response rate(ORR) and overall survival OS.
Objective Response Rate Based on IRR.
Secondary efficacy endpoints included progression-free survival and objective response rate.
Objective Response Rate n(%) by Investigator Assessment.
The primary efficacy endpoint in both studies was objective response rate(ORR) according to RECIST.
The objective response rate(ORR) based on MRI scans was 8.
The primary endpoints of the trial were objective response rate and progression-free survival.
Objective Response Rate(ORR)^- secondary endpoint no. of patients with measurable disease.
Among patients who had progressed on vemurafenib(n=66), the objective response rate was 15.
P-value< 0.0001 Objective Response Rate(%) in Patients with Measurable Disease n.
These patients(n=16) showed significant prolongation of PFS(HR of 0.15) and an objective response rate of 31.
The objective response rate by RECIST in the Tarceva group was 8.9% 95% CI, 6.4 to 12.0.
Secondary endpoints included safety, objective response rate, response duration and overall survival OS.
B Objective response rate= proportion of patients with complete
Key secondary efficacy outcome measures were overall survival(OS) and objective response rate(ORR) see Table 3.
The objective response rate for fulvestrant was 19.2% compared with 16.5% for anastrozole.
Key secondary efficacy outcome measures were investigator-assessed objective response rate(ORR) and progression-free survival PFS.
Objective response rate was low in both treatment arms
p-value for Objective Response Rate based on logistic regression.
Objective response rate and progression free survival time were significantly improved with cetuximab.
Palladia-treated dogs had a significantly greater objective response rate(37.2%) compared to dogs treated with placebo 7.9.
Objective response rate and duration of response are based on IRF-assessed tumour assessments.
Statistically significant improvements in progression-free survival and objective response rate were also observed see Table 7.
The objective response rate(ORR) was 58.0% with trastuzumab plus docetaxel
Additional outcome measures included Progression Free Survival(PFS) and Objective Response Rate ORR.